| mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.027 |
0.9 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0075 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
-0.026 |
0.9 |
| mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |